# Efficacy and Safety of Sorafenib in Previously Treated Advanced Hepatocellular Carcinoma: SOPT Study

> **NCT05117957** · PHASE2 · COMPLETED · sponsor: **Bo Hyun Kim** · enrollment: 50 (actual)

## Conditions studied

- Advanced Hepatocellular Carcinoma

## Interventions

- **DRUG:** Sorafenib

## Key facts

- **NCT ID:** NCT05117957
- **Lead sponsor:** Bo Hyun Kim
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-08
- **Primary completion:** 2025-06-30
- **Final completion:** 2025-12-18
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2025-12-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05117957

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05117957, "Efficacy and Safety of Sorafenib in Previously Treated Advanced Hepatocellular Carcinoma: SOPT Study". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05117957. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*